Charles River Laboratories International Inc. Stock Rises 7.1%, Outperforms Peers
Dow Jones2026/10/05 20:33This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Charles River Laboratories International Inc. advanced 7.1% to $310.77 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.7% to 7,773.95 and the Dow Jones Industrial Average rising 0.2% to 51,267.90. This was the stock's second consecutive day of gains. Charles River Laboratories International Inc. hit a new 52-week high, surpassing its previous peak of $303.31, which the company reached on August 27th. The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 0.1% to $308.65, Alnylam Pharmaceuticals Inc. rose 0.1% to $219.89, and Bio-Techne Corp. rose 0.25% to $72.58. Trading volume totaled 1.3 million, compared to the 50-day average of 936,013. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 05, 2026 16:33 ET (20:33 GMT)
This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. advanced 7.1% to $310.77 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.7% to 7,773.95 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.
This was the stock's second consecutive day of gains.
Charles River Laboratories International Inc. hit a new 52-week high, surpassing its previous peak of $303.31, which the company reached on August 27th.
The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 0.1% to $308.65, Alnylam Pharmaceuticals Inc. rose 0.1% to $219.89, and Bio-Techne Corp. rose 0.25% to $72.58.
Trading volume totaled 1.3 million, compared to the 50-day average of 936,013.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 05, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Coca-Cola FEMSA Shares Rise After JPMorgan Upgrade
Bank of Canada: Inflation-growth tradeoff keeps policy on hold – RBC
Data: If ETH breaks above $2,537, the cumulative short liquidation intensity on major CEXs will reach $862 millions.
Crypto prices
More
